Optometrists in Sandusky, MI Accepting Medicare
8 Optometrists found. Showing 1 - 8
 Family Eye Care Of Sandusky, Pc Optometrist Medicare: Medicare Enrolled Practice Location: 454 W Sanilac Rd, Sandusky, MI 48471 Phone: 810-648-2020 |
 Mr. Stephan Carl Jankowski, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 93 S Morse St, Sandusky, MI 48471 Phone: 810-648-2456 Fax: 810-648-5279 |
 Dr. Tracy Scott, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 454 W Sanilac Rd, Sandusky, MI 48471 Phone: 810-648-2020 |
Christina Ann Hicks-hubbard, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2175 Hull Rd, Sandusky, MI 48471 Phone: 810-705-3158 |
Primary Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 33 W Sanilac Rd, Sandusky, MI 48471 Phone: 810-648-4242 Fax: 810-648-4248 |
George William Mcniven, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 33 W Sanilac Rd, Box 112, Sandusky, MI 48471 Phone: 810-648-4242 |
Dr. Ronald Raymond Watson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 43 Kristian St, Sandusky, MI 48471 Phone: 810-648-3100 |
Dr. Brendon Allen Manns, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 454 W Sanilac Rd, Sandusky, MI 48471 Phone: 810-648-2020 |
News Archive
Supportive data from a preclinical study of SCY-635 to be presented
Drug discovery company SCYNEXIS, Inc. today announced that supportive data from a preclinical study of the Company's lead product candidate for hepatitis C (HCV), SCY-635, will be presented in a poster session at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) being held in Boston, MA, October 30-November 3, 2009.
Democrats target a dozen GOP senators in quest for health reform deal
Senate Finance Committee Chairman Max Baucus and other Democratic leaders are targeting more than a dozen moderate and conservative Republicans as they pursue a bipartisan deal to extend health care coverage to nearly 46 million uninsured Americans.
Dexamethasone use could reduce immune checkpoint inhibitor efficacy in glioblastoma patients
Bottom Line: Among patients with glioblastoma receiving an immune checkpoint inhibitor, those who received the corticosteroid dexamethasone at baseline for cerebral edema had significantly worse overall survival.
Infinity announces new data from IPI-145 Phase 1 trial on advanced hematologic malignancies
Infinity Pharmaceuticals, Inc. today announced new data from its ongoing Phase 1, open-label, dose-escalation trial of IPI-145, the company's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, in patients with advanced hematologic malignancies.
› Verified 1 days ago
Optometrists
Occupational Therapists
Chiropractors
Podiatrists
Physical Therapists
Speech-Language Pathologists
Audiologists